Next Article in Journal
Debridement of the Noninfected Wound
Previous Article in Journal
Toe and Flo Essential Components and Structure of the Amputation Prevention Team
 
 
Journal of the American Podiatric Medical Association is published by MDPI from Volume 116 Issue 1 (2026). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with American Podiatric Medical Association.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

What You Can’t Feel Can Hurt You

by
Andrew J. M. Boulton
Manchester Diabetes Centre, 193 Hathersage Rd, Manchester M13 0JE, England
J. Am. Podiatr. Med. Assoc. 2010, 100(5), 349-352; https://doi.org/10.7547/1000349
Published: 1 September 2010

Abstract

Throughout our medical training, we are taught how to manage patients who present with symptoms: perform a clinical examination, make a diagnosis, and develop a management plan. However, virtually no time is spent on teaching us how to manage patients who have no symptoms because they have lost the ability to feel pain, that is, patients with peripheral neuropathy. The lifetime incidence of foot ulceration in people with diabetes has been estimated to be as high as 25%, and a variety of contributory factors result in a foot being at risk for ulceration. Most important among these factors is peripheral neuropathy, or the loss of the ability to feel pain, temperature, or pressure sensation in the feet and lower legs. Up to 50% of older type 2 diabetic patients have evidence of sensory loss, putting them at risk for foot ulceration. If we are to succeed in reducing the high incidence of foot ulcers, regular screening for peripheral neuropathy is vital in all patients with diabetes. Those found to have any risk factors for foot ulceration require special education and more frequent review, particularly by podiatric physicians. The key message is, therefore, that neuropathic symptoms correlate poorly with sensory loss and that their absence must never be equated with lack of risk of foot ulceration. If we are to succeed in reducing the high incidence of foot ulceration and particularly recurrent ulceration, we must realize that with loss of pain there is also diminished motivation in the healing and prevention of injury. (J Am Podiatr Med Assoc 100(5): 349–352, 2010)

Pain is God’s greatest gift to mankind.
Paul Brand, MD
It was Dr. Paul Brand working with patients with Hansen’s disease in South India who recognized that it was the loss of peripheral sensation in the limbs of those patients with leprosy that resulted in the terrible scarring and ulceration that occurred in these individuals. Pain is indeed a gift, but the gift of pain is recognized only when it is lost because it is the protective sensation that prevents us from further damaging areas of injury. Similar to patients with Hansen’s disease, patients with sensory loss secondary to diabetes that predominates in the lower limb frequently develop ulcers and even more serious conditions, such as Charcot’s neuroarthropathy, because they have lost this gift of pain. A reduction in neuropathic foot problems will be achieved only if we remember that those with insensitive feet have lost this warning signal of pain that ordinarily brings them to their physicians.
The identification and care of a patient with no pain sensation is a new challenge for which most of us have little, if any, training. It is difficult for us to understand, for example, that an intelligent patient would buy and wear a pair of shoes several sizes too small and come to our clinic with an extensive shoe-induced ulcer. The explanation, however, is simple: with reduced sensation, a very tight fit stimulates the remaining pressure nerve endings, which is interpreted by that individual as a normal fit; hence, the common complaint when we provide patients with custom-designed shoes is, “These shoes are too loose.” We can learn much about the management of patients with diabetic neuropathy from the treatment of patients with Hansen’s disease [1]. If we are to succeed, we must realize that with loss of pain there is also diminished motivation in the healing and prevention of injury.
Because the lifetime incidence of foot ulceration in diabetic patients has been estimated to be as high as 25% [2], understanding the pathways that result in the development of an ulcer is increasingly important. The Scottish poet Thomas Campbell wrote, “Coming events cast their shadows before.” These words can usefully be applied to the breakdown of the diabetic foot because ulceration does not spontaneously occur but is a combination of causative factors that results in the development of a lesion. Thus, there are many warning signs or “shadows” that can identify those at risk. Other articles in this issue cover the important area of peripheral vascular disease in the causation of lower-extremity problems, and in this review, I focus on the most common of the diabetic neuropathies, chronic sensorimotor neuropathy, which is a major contributory factor in the pathway to ulceration in diabetes. In the final section of this article I discuss simple methods to screen for the high-risk patient with foot ulcer that are based on the recently published Comprehensive Diabetic Foot Examination by a task force of the American Diabetes Association [3].

Chronic Sensorimotor Diabetic Peripheral Neuropathy

Of all of the neuropathies of diabetes, the chronic sensorimotor variety, diabetic peripheral neuropathy, is by far the most common. Indeed, it has been estimated that up to 50% of older type 2 diabetic patients may have evidence of sensory loss on clinical examination and, therefore, must be considered at risk for insensitive foot injury [4]. In the large United Kingdom Prospective Diabetes Study [4], 13% of patients at diagnosis of type 2 diabetes were found to have sensory loss of sufficient severity to put them at risk for insensitive foot lesions: this provides a clear message, and that is people with any duration of type 2 diabetes might be at significant risk for foot problems.
Diabetic peripheral neuropathy commonly results in sensory loss confirmed on examination by a deficit in the stocking distribution to all sensory modalities: evidence of motor dysfunction in the form of small muscle wasting is also often present. Whereas some patients might give a history (past or present) of typical neuropathic symptoms, such as burning pain, stabbing discomfort, and paresthesia with nocturnal exacerbation, others might develop sensory loss without ever having any such history. Some patients might have the “painful-painless” leg with spontaneous discomfort secondary to neuropathic symptoms but on examination have small and large fiber sensory deficits. Such patients are also at great risk for painless injury to their feet.
From these points it should be clear that a spectrum of symptomatic severity may be present, with some patients experiencing severe pain and, at the other end of the spectrum, others who have no spontaneous symptoms, but both groups may have significant sensory loss on clinical examination. The most challenging patients are, indeed, those who develop sensory loss with no history of symptoms because it is often difficult to convince them that they are at risk for foot ulceration because they feel no discomfort, and motivation to perform regular foot self-care is difficult. The key message is that neuropathic symptoms correlate poorly with sensory loss, and their absence must never be equated with lack of foot ulcer risk. Thus, in the assessment of foot ulcer risk, a careful foot examination after removal of shoes and socks must always be included whatever the symptom history [4], hence the clinical observation by Dr. Paul Brand that any patient who walks into the clinic with a foot ulcer but without a limp must have neuropathy because those with normal pain sensation would not be able to put weight on the lesion.
Most patients with significant risk of foot ulceration due to sensory loss also have peripheral autonomic dysfunction affecting the sympathetic nervous system. This results in reduced sweating and, in the absence of large vessel obstructive vascular disease, increased blood flow to the foot with arteriovenous shunting leading to the warm, but insensate foot.

Other Risk Factors

The neuropathic insensate foot does not ulcerate spontaneously: it is a combination of factors that ultimately results in breakdown and ulceration. Factors that increase the risk of foot ulceration are listed in Table 1. The highest-risk populations are those with a history of ulceration or even amputation. Several studies have shown that other late complications of diabetes include nephropathy (particularly in those undergoing dialysis or after transplantation) and retinopathy (particularly if there is visual loss). There seems to be a temporal relationship between starting dialysis and risk of foot ulcers [5].
Table 1. Factors That Increase the Risk of Diabetic Foot Ulceration.
Table 1. Factors That Increase the Risk of Diabetic Foot Ulceration.
Japma 100 00349 i001
Other important contributory factors to ulcers include the presence of callus or hard skin under weightbearing areas (this occurs as a consequence of pressure plus dry skin due to autonomic neuropathy) and foot deformity. A combination of motor neuropathy, limited joint mobility, and altered gait patterns are thought to result in the “high-risk” neuropathic foot with clawing of the toes, prominent metatarsal heads, a high arch, and small muscle wasting.

Pathway to Ulceration

It is the combination of two or more risk factors that ultimately results in breakdown of the diabetic foot. In a study of instant foot ulcers, Reiber et al. [6] showed that the most common triad of component causes resulting in ulceration is neuropathy (loss of pain sensation), foot deformity, and trauma. Other important component causes in the pathway to ulceration include edema and ischemia.

Screening for Foot Ulcers

Superior doctors prevent the disease: mediocre doctors treat the disease before evident: inferior doctors treat the full blown disease.
Huang Dee Nai-Chang, 2600 bc
1st Chinese Medical Text
This Chinese proverb is probably true, and there needs to be a shift from most being inferior colleagues to being superior, which means identifying those at risk and providing foot-care education and regular assessments and treatment, preventing foot ulcers from actually occurring. Many countries have now adopted the principle of “the annual review” for patients with diabetes, where every patient is screened at least annually for evidence of diabetic complications. Such a review can be conducted either in primary care or in a hospital diabetic clinic.
A task force of the American Diabetes Association recently addressed the question of what should be included in the annual review in the Comprehensive Diabetic Foot Examination [3]. This group addressed and concisely summarized the recent literature in the area and recommended using evidence-based medicine where possible, which should be included in the Comprehensive Diabetic Foot Examination for adult patients with diabetes. The main emphasis of this report was on a concise clinical examination to identify the patient at risk. A summary of the key components of the Comprehensive Diabetic Foot Examination is provided in Table 2. Whereas each potential simple neurologic clinical assessment has advantages and disadvantages, it was believed that the 10-g monofilament had much evidence to support its use, hence the recommendation that assessment of neuropathy should always comprise the use of such a filament plus one other confirmatory test. In addition to the simple tests listed in Table 2, one possible test that was also included was the vibration perception threshold using a biothesiometer or vibration perception threshold meter. Although this is a semiquantitative test of sensation, it was included because many centers in North America and Europe have such equipment. However, as can be seen from Table 2, this is not regarded as essential, so the Comprehensive Diabetic Foot Examination can be performed with simple clinical tools not requiring any external power source.
Table 2. Key Components of the Comprehensive Diabetic Foot Examinationa
Table 2. Key Components of the Comprehensive Diabetic Foot Examinationa
Japma 100 00349 i002
As can be seen, although the neuropathic foot is at great risk for ulceration, this need not occur, and most such ulcers should be preventable. This depends on realization by the patients themselves that they are at risk for foot ulcers and the application of simple foot self-care such as regular inspection and podiatric medical care. However, it remains depressing that there are still reports that many patients are not receiving regular foot screens; if we, as physicians, fail to examine patients’ feet when we occasionally see them, can we honestly expect them to examine their feet daily?

Financial Disclosure

None reported.

Conflict of Interest

None reported.

References

  1. Brand PW. “Diabetic Foot,”. In Diabetes Mellitus: Theory and Practice, 3rd ed.; ed by M Ellenberg, H Rifkin, p 829; Medical Examination Publishing: New York, NY, USA, 1983. [Google Scholar]
  2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293, 217. [Google Scholar]
  3. Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008, 31, 1679. [Google Scholar]
  4. Boulton AJ, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care 2004, 27, 1458. [Google Scholar]
  5. Game FL, Chipchase SY, Hubbard R, et al. Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant 2006, 21, 3207. [Google Scholar]
  6. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22, 157. [Google Scholar]

Share and Cite

MDPI and ACS Style

Boulton, A.J.M. What You Can’t Feel Can Hurt You. J. Am. Podiatr. Med. Assoc. 2010, 100, 349-352. https://doi.org/10.7547/1000349

AMA Style

Boulton AJM. What You Can’t Feel Can Hurt You. Journal of the American Podiatric Medical Association. 2010; 100(5):349-352. https://doi.org/10.7547/1000349

Chicago/Turabian Style

Boulton, Andrew J. M. 2010. "What You Can’t Feel Can Hurt You" Journal of the American Podiatric Medical Association 100, no. 5: 349-352. https://doi.org/10.7547/1000349

APA Style

Boulton, A. J. M. (2010). What You Can’t Feel Can Hurt You. Journal of the American Podiatric Medical Association, 100(5), 349-352. https://doi.org/10.7547/1000349

Article Metrics

Back to TopTop